| # | Title | Journal | Year | Citations |
|---|
| 1 | Vimentin in cancer and its potential as a molecular target for cancer therapy | Cellular and Molecular Life Sciences | 2011 | 1,192 |
| 2 | Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism | ELife | 2016 | 681 |
| 3 | Current and future therapeutic approaches for osteosarcoma | Expert Review of Anticancer Therapy | 2018 | 539 |
| 4 | EMT, CTCs and CSCs in tumor relapse and drug-resistance | Oncotarget | 2015 | 408 |
| 5 | Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles | Modern Pathology | 2005 | 322 |
| 6 | Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults | Blood | 2017 | 285 |
| 7 | Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target | Journal of Clinical Investigation | 2018 | 242 |
| 8 | Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology Group | Blood | 2017 | 236 |
| 9 | Clinical and molecular characterization of early‐onset colorectal cancer | Cancer | 2019 | 212 |
| 10 | Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen–Matched Unrelated and Related Donors | Biology of Blood and Marrow Transplantation | 2014 | 207 |
| 11 | Epithelial–Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression | Clinical Cancer Research | 2015 | 199 |
| 12 | Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy | Nature Reviews Clinical Oncology | 2019 | 178 |
| 13 | Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experience. | Journal of Clinical Oncology | 1990 | 174 |
| 14 | Preventing Neurocognitive Late Effects in Childhood Cancer Survivors | Journal of Child Neurology | 2008 | 167 |
| 15 | Technologies for deriving primary tumor cells for use in personalized cancer therapy | Trends in Biotechnology | 2013 | 164 |
| 16 | Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients | Scientific Reports | 2016 | 152 |
| 17 | Autologous Bone Marrow Mononuclear Cell Therapy for Severe Traumatic Brain Injury in Children | Neurosurgery | 2011 | 143 |
| 18 | Immuno-genomic landscape of osteosarcoma | Nature Communications | 2020 | 143 |
| 19 | Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma | JAMA Oncology | 2020 | 139 |
| 20 | A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily | Cell Systems | 2018 | 134 |
| 21 | Surgical management of hereditary pheochromocytoma1 1No competing interests declared. | Journal of the American College of Surgeons | 2004 | 120 |
| 22 | Ex vivo expansion of cord blood | Bone Marrow Transplantation | 2009 | 115 |
| 23 | The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis | Gut | 2016 | 111 |
| 24 | Pronounced Hypoxia in Models of Murine and Human Leukemia: High Efficacy of Hypoxia-Activated Prodrug PR-104 | PLoS ONE | 2011 | 108 |
| 25 | Imaging Changes in Pediatric Intracranial Ependymoma Patients Treated With Proton Beam Radiation Therapy Compared to Intensity Modulated Radiation Therapy | International Journal of Radiation Oncology Biology Physics | 2015 | 108 |
| 26 | Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and BrafV600E-Induced Tumorigenesis | Cancer Cell | 2019 | 107 |
| 27 | IL‐30 (IL27p28) attenuates liver fibrosis through inducing NKG2D‐rae1 interaction between NKT and activated hepatic stellate cells in mice | Hepatology | 2014 | 105 |
| 28 | EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression | Oncotarget | 2017 | 105 |
| 29 | Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway | Gastroenterology | 2018 | 105 |
| 30 | Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention | Advances in Experimental Medicine and Biology | 2020 | 104 |
| 31 | Gene Therapy with the Sleeping Beauty Transposon System | Trends in Genetics | 2017 | 92 |
| 32 | Kasabach-Merritt Phenomenon | Journal of Pediatric Hematology/Oncology | 2009 | 91 |
| 33 | Outcomes and Acute Toxicities of Proton Therapy for Pediatric Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System | International Journal of Radiation Oncology Biology Physics | 2014 | 89 |
| 34 | Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells | Stem Cells | 2017 | 89 |
| 35 | Strategies for combining immunotherapy with radiation for anticancer therapy | Immunotherapy | 2015 | 83 |
| 36 | Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group | British Journal of Cancer | 2018 | 83 |
| 37 | Outcomes of Pediatric Patients with Malignancies of the Major Salivary Glands | Annals of Surgical Oncology | 2010 | 79 |
| 38 | Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly‐diagnosed with central nervous system atypical teratoid/rhabdoid tumors: The head start III experience | Pediatric Blood and Cancer | 2014 | 79 |
| 39 | Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions | OncoImmunology | 2020 | 75 |
| 40 | Cell‐surface Vimentin: A mislocalized protein for isolating csVimentin+CD133− novel stem‐like hepatocellular carcinoma cells expressing EMT markers | International Journal of Cancer | 2015 | 74 |
| 41 | Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC) | Clinical Lymphoma, Myeloma and Leukemia | 2016 | 74 |
| 42 | Navigating financial toxicity in patients with cancer: A multidisciplinary management approach | Ca-A Cancer Journal for Clinicians | 2022 | 73 |
| 43 | IL‐27 enhances the survival of tumor antigen‐specific CD8+ T cells and programs them into IL‐10‐producing, memory precursor‐like effector cells | European Journal of Immunology | 2013 | 71 |
| 44 | Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Children, Adolescents, and Young Adults: The First 50 Cases | Annals of Surgical Oncology | 2015 | 70 |
| 45 | Improved Neuropsychological Outcome in Children With Brain Tumors Diagnosed During Infancy and Treated Without Cranial Irradiation | Journal of Child Neurology | 1992 | 66 |
| 46 | Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation | Bone Marrow Transplantation | 1999 | 66 |
| 47 | Anti–PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells | Clinical Cancer Research | 2020 | 65 |
| 48 | Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures | PLoS ONE | 2011 | 64 |
| 49 | Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosarcoma) | Expert Opinion on Investigational Drugs | 2008 | 63 |
| 50 | Current therapy and the evolving molecular landscape of paediatric ependymoma | European Journal of Cancer | 2017 | 63 |
